Clinical Trial Update: Gene Therapy in Treating Patients With Recurrent Malignant Gliomas [Phase 1]

View source ↗

Summary

A Phase 1 gene therapy trial for patients with recurrent malignant gliomas has completed enrollment and a status update has been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED